Usv Pharmaceutical Corporation

Rorer Pharmaceutical Corporation

Rhone-poulenc Rorer Pharmaceuticals Inc.

Paul R Menard

John T Suh

Howard Jones

John J Piwinski

John R Regan

Edward S Neiss

Charles E Pendley, Ii

Kin T Yu

Jerry W Skiles

Robert G Pendleton

Alain B Schreiber

Jeffrey N Barton

James J Mencel

Robert G Pendelton

Tihamer Herczeg

Disclosed are pharmaceutical compositions containing naphthoic acid derivatives and method of use for enhancing oxygen availability to mammailian tissue.

Treatment of conditions requiring enhanced oxygen availability of

Treatment of conditions requiring enhanced oxygen availability to

Disclosed are pharmaceutical compositions containing certain heterocylcic sulphonamido azo compounds for enhancing oxygen availability to mammalian tissue.

Compounds having the general structure ##STR1## and their pharmaceutically acceptable salts, wherein the substituents are defined herein, which exhibit antihypertensive activity.

Antihypertensive derivatives

Carboxyalkyl dipeptide compounds

Compounds of the formula ##STR1## and their pharmaceutically acceptable salts, wherein the substituents are as defined herein, having antihypertensive activity.

Compounds for treating hypertension

Compounds having the general structure ##STR1## and their pharmaceutically acceptable salts, wherein the substitutents are defined herein, which exhibit antihypertensive activity.

Antihypertensive spiro-amidoamino compounds

Antihypertensive spiro-cyclic compounds

Compounds of the structure ##STR1## wherein: P and Q are independently hydrogen, halo, CF.sub.3, OR.sub.1, SR.sub.1, sulfamoyl, alkyl and NR.sub.1 R.sub.2 ;

Aroylaminoacid disulfides

Compounds of the structure ##STR1## wherein: Q is oxygen, sulfur or imino.

Growing community of inventors

North Wales, PA, United States of America

Paul R Menard